OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transcriptional regulation of Hepatic Stellate Cell activation in NASH
Ann-Britt Marcher, Sofie M. Bendixen, Mike Krogh Terkelsen, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1254

Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Robert F. Schwabe, Ira Tabas, Utpal B. Pajvani
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1913-1928
Open Access | Times Cited: 490

Pathophysiological mechanisms of liver injury in COVID‐19
Alexander D Nardo, Mathias Schneeweiss‐Gleixner, May Bakail, et al.
Liver International (2020) Vol. 41, Iss. 1, pp. 20-32
Open Access | Times Cited: 366

UCP1 governs liver extracellular succinate and inflammatory pathogenesis
Evanna L. Mills, Cathal Harmon, Mark P. Jedrychowski, et al.
Nature Metabolism (2021) Vol. 3, Iss. 5, pp. 604-617
Open Access | Times Cited: 115

Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review
Narjes Nasiri‐Ansari, Θεόδωρος Ανδρουτσάκος, Christina‐Maria Flessa, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2511-2511
Open Access | Times Cited: 76

Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Shuang Wang, Scott L. Friedman
Science Translational Medicine (2023) Vol. 15, Iss. 716
Open Access | Times Cited: 55

Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis
Thomas Savage, Katherine T. Fortson, Kenia de los Santos-Alexis, et al.
Immunity (2024) Vol. 57, Iss. 2, pp. 303-318.e6
Open Access | Times Cited: 25

Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
Arshi Khanam, Paul Saleeb, Shyam Kottilil
Cells (2021) Vol. 10, Iss. 5, pp. 1097-1097
Open Access | Times Cited: 82

Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis
Zhongyi Wang, Adrian Keogh, Annick Waldt, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 78

Transcriptional Dynamics of Hepatic Sinusoid‐Associated Cells After Liver Injury
Mike Krogh Terkelsen, Sofie M. Bendixen, Daniel Hansen, et al.
Hepatology (2020) Vol. 72, Iss. 6, pp. 2119-2133
Open Access | Times Cited: 75

Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model
Mohamed Elbadawy, Megumi Yamanaka, Yuta Goto, et al.
Biomaterials (2020) Vol. 237, pp. 119823-119823
Closed Access | Times Cited: 70

Liver lipophagy ameliorates nonalcoholic steatohepatitis through extracellular lipid secretion
Yoshito Minami, Atsushi Hoshino, Yusuke Higuchi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 38

Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis
Johanna K. DiStefano
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 11, pp. 2079-2090
Open Access | Times Cited: 69

C57BL/6J substrain differences in response to high-fat diet intervention
Majken Siersbæk, Nicholas Ditzel, Eva Kildall Hejbøl, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 64

Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis
Mingtai Chen, Ying Xie, Shenglan Gong, et al.
Pharmacological Research (2021) Vol. 172, pp. 105849-105849
Closed Access | Times Cited: 51

Metabolic Reprogramming of Liver Fibrosis
M. Eugenia Delgado, Beatriz Cárdenas, Núria Farran, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3604-3604
Open Access | Times Cited: 45

Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis
Man Wang, Lei Li, Yannan Xu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29

Fibroblasts in liver cancer: functions and therapeutic translation
Silvia Affò, Aveline Filliol, Gregory J. Gores, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 8, pp. 748-759
Open Access | Times Cited: 19

Single cell multiomic analysis reveals diabetes-associated β-cell heterogeneity driven by HNF1A
Chen Weng, Anniya Gu, Shanshan Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19

Lipidomic profiling of rat hepatic stellate cells during activation reveals a two-stage process accompanied by increased levels of lysosomal lipids
Martijn R. Molenaar, Maya W. Haaker, Arie B. Vaandrager, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 4, pp. 103042-103042
Open Access | Times Cited: 17

Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosis
Marie Bobowski, Clémence Boulet, Francesco Paolo Zummo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26

Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis
Daniela Gabbia, Marco Roverso, Maria Guido, et al.
Nutrients (2019) Vol. 11, Iss. 7, pp. 1602-1602
Open Access | Times Cited: 39

MicroRNAs and their delivery in diabetic fibrosis
Alexa Wonnacott, Laura Denby, Richard J. Coward, et al.
Advanced Drug Delivery Reviews (2021) Vol. 182, pp. 114045-114045
Open Access | Times Cited: 31

Dysregulation of murine long noncoding single-cell transcriptome in nonalcoholic steatohepatitis and liver fibrosis
Kritika Karri, David J. Waxman
RNA (2023) Vol. 29, Iss. 7, pp. 977-1006
Open Access | Times Cited: 11

Page 1 - Next Page

Scroll to top